Le Lézard
Classified in: Science and technology, Business
Subject: PDT

Flash News: OKX Lists ZeroLend's Token on its Spot Market


DUBAI, UAE, May 6, 2024 /PRNewswire/ -- OKX, a leading crypto exchange and Web3 technology company, has issued updates for May 6, 2024.

OKX Lists ZeroLend's Token on its Spot Market

OKX today announced that it has listed ZeroLend's governance and utility token, ZERO, on its spot market, thus expanding trading options for its users. This addition enables eligible users to trade ZERO against USDT.

Deposits for the token were enabled on May 3 at 8:00 AM (UTC), while spot trading for the ZERO/USDT pair began on May 6 at 8:00 AM (UTC).

ZeroLend is one of the fastest-growing multi-chain lending protocols, focusing on Liquid Restaking Tokens (LRTs), Real-World Assets (RWAs), privacy and account abstraction.

For more information, please visit the Support Center.

For further information, please contact:
[email protected]

About OKX

OKX is a leading global crypto exchange and innovative Web3 company. Trusted by more than 50 million global users, OKX is known for being one of the fastest and most reliable crypto apps in the world.

To learn more about OKX, download our app or visit: okx.com

Disclaimer

SOURCE OKX


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: